Homepage
Author:
Apertura Gene Therapy
Posted Date:
February 18, 2026
Finding Hope for Frizzle (FRRS1L) and Apertura Gene Therapy Announce License Agreement for the Development of a Gene Therapy Using TfR1 CapX, an AAV Capsid Designed to Target the Central Nervous System
Apertura Gene Therapy
February 18, 2026
Apertura Gene Therapy Launches Open Aperture, a Material Transfer Agreement Program to Facilitate Non-Commercial Access to TfR1 CapX for Academic Researchers
Apertura Gene Therapy
February 12, 2026
